Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/34161
Title: Systemic manifestations of primary Sjogren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients
Authors: RETAMOZO, S.ACAR-DENIZLI, N.RASMUSSEN, A.HORVATH, I. F.BALDINI, C.PRIORI, R.SANDHYA, P.HERNANDEZ-MOLINA, G.ARMAGAN, B.PRAPROTNIK, S.KVARNSTROM, M.GERLI, R.SEBASTIAN, A.SOLANS, R.RISCHMUELLER, M.PASOTO, S. G.VALIM, V.NORDMARK, G.KRUIZE, A. A.NAKAMURA, H.HOFAUER, B.GIACOMELLI, R.TREVISANI, V. Fernandes MocaDEVAUCHELLE-PENSEC, V.ATZENI, F.GHEITA, T. A.CONSANI-FERNANDEZ, S.SZANTO, A.SIVILS, K.GATTAMELATA, A.DANDA, D.KILIC, L.BARTOLONI, E.BOMBARDIERI, S.SANCHEZ-GUERRERO, J.WAHREN-HERLENIUS, M.MARIETTE, X.RAMOS-CASALS, M.BRITO-ZERON, P.
Citation: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, v.37, n.3, suppl.118, p.S97-S106, 2019
Abstract: Objectives: To analyse the frequency and characterise the systemic presentation of primary Sjogren's syndrome (SS) out of the ESSDAI classification in a large international, multi-ethnic cohort of patients. Methods: The Big Data Sjogren Project Consortium is an international, multicentre registry based on world-wide data-sharing and cooperative merging of pre-existing clinical SS databases from leading centres in clinical research in SS from the five continents. A list of 26 organ-by-organ systemic features not currently included in the ESSDAI classification was defined according to previous studies; these features were retrospectively recorded. Results: Information about non-ESSDAI features was available in 6331 patients [5,917 female, mean age at diagnosis 52 years, mainly White (86.3%)]. A total of 1641 (26%) patients had at least one of the ESSDAI systemic features. Cardiovascular manifestations were the most frequent organ-specific group of non-ESSDAI features reported in our patients (17% of the total cohort), with Raynaud's phenomenon being reported in 15%. Patients with systemic disease due to non-ESSDAI features had a lower frequency of dry mouth (90.7% vs. 94.1%, p<0.001) and positive minor salivary gland biopsy (86.7% vs. 89%, p=0.033), a higher frequency of anti-Ro/SSA (74.7% vs. 68.7%, p<0.001), anti-La/SSB antibodies (44.5% vs. 40.4%, p=0.004), ANA (82.7% vs. 79.5%, p=0.006), low C3 levels (17.4% vs. 9.7%, p<0.001), low C4 levels (14.4% vs. 9.6%, p<0.001), and positive serum cryoglobulins (8.6% vs. 5.5%, p=0.001). Systemic activity measured by the ESSDAI, clinESSDAI and DAS was higher in patients with systemic disease out of the ESSDAI in comparison with those without these features (p<0.001 for all comparisons). Conclusions: More than a quarter of patients with primary SS may have systemic manifestations not currently included in the ESSDAI classification, with a wide variety of cardiovascular, digestive, pulmonary, neurological, ocular, ENT (ear, nose, and throat), cutaneous and urological features that increase the scope of the systemic phenotype of the disease. However, the individual frequency of each of these non-ESSDAI features was very low, except for Raynaud's phenomenon.
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - LIM/03
LIM/03 - Laboratório de Medicina Laboratorial


Files in This Item:
File Description SizeFormat 
art_RETAMOZO_Systemic_manifestations_of_primary_Sjogrens_syndrome_out_of_2019.PDF
  Restricted Access
publishedVersion (English)1.08 MBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.